Medrhythms utilizes sensors, music, and software to develop evidence-based, neurologic interventions to measure and improve walking.
Medrhythms has raised $3.3M in total funding. The most recent round was Series Unknown. The last funding was announced in March 2026.
Medrhythms's investors include Global Brain Corporation, Bose Ventures, Advantage Capital, Morningside, Maine Venture Fund.
Medrhythms is headquartered in Boston, United States.
Medrhythms utilizes sensors, music, and software to develop evidence-based, neurologic interventions to measure and improve walking.
Medrhythms is at the Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Medrhythms — Funding & Investors." VCBacked, March 2, 2026, https://www.vcbacked.co/company/medrhythms. Accessed September 30, 2026.
VCBacked. (2026). Medrhythms — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/medrhythms
{{cite web |title=Medrhythms — Funding & Investors |url=https://www.vcbacked.co/company/medrhythms |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated